These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11680732)

  • 1. Chimeric pig hearts resist hyperacute rejection in ex vivo perfusion model.
    Yang T; Stammers A; Jiang J; Shearon C; Thompson S; Beschorner WE
    J Extra Corpor Technol; 2001 Sep; 33(3):181-4. PubMed ID: 11680732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surrogate tolerogenesis on the vascular rejection of pig heart xenografts.
    Sudan DL; Radio SJ; Matamoros A; Johnson ND; Shearon CC; Glogowski KR; Hill AC; Goertzen TC; Fox IJ; Langnas AN; Beschorner WE
    Transplantation; 2000 Jan; 69(2):232-5. PubMed ID: 10670632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B
    Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart xenograft survival with chimeric pig donors and modest immune suppression.
    Beschorner WE; Sudan DL; Radio SJ; Yang T; Franco KL; Hill AC; Shearon CC; Thompson SC; Dixon RS; Johnson ND; Kuszynski CA; Rubocki RJ; Lechtenberg KF; Matamoros A; Goertzen TC; Fox IJ; Langnas AN
    Ann Surg; 2003 Feb; 237(2):265-72. PubMed ID: 12560785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.
    Kroshus TJ; Dalmasso AP; Leventhal JR; John R; Matas AJ; Bolman RM
    J Surg Res; 1995 Jul; 59(1):43-50. PubMed ID: 7630135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplantation; 1996 Jul; 62(1):5-12. PubMed ID: 8693544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
    Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
    Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection.
    Kirk AD; Heinle JS; Mault JR; Sanfilippo F
    Transplantation; 1993 Oct; 56(4):785-93. PubMed ID: 8212196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements.
    Lin X; Qi JZ; Chen MH; Qiu BT; Huang ZH; Qiu PX; Chen JS; Yan GM
    Biochem Pharmacol; 2013 Mar; 85(6):772-9. PubMed ID: 23178656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart model.
    Dunning JJ; Pierson RN; Braidley PC; White DJ; Wallwork J
    Eur J Cardiothorac Surg; 1994; 8(4):204-6. PubMed ID: 8031564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
    Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
    Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2.
    Ross JR; Kirk AD; Ibrahim SE; Howell DN; Baldwin WM; Sanfilippo FP
    Transplantation; 1993 May; 55(5):1144-50. PubMed ID: 8497896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
    Lexer G; Cooper DK; Rose AG; Wicomb WN; Rees J; Keraan M; Du Toit E
    J Heart Transplant; 1986; 5(6):411-8. PubMed ID: 3302173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human plasma causes rapid dysfunction in ex vivo pig hearts.
    Robbins RC; Mitchell ME; Sachs DH; Clark RE
    J Heart Lung Transplant; 1994; 13(5):877-81. PubMed ID: 7803431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ischemic time on hyperacute xenograft rejection of pig hearts in a working heart perfusion model with human blood.
    Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S494-503. PubMed ID: 11112061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection.
    Robson SC; Young VK; Cook NS; Metternich R; Kasper-Konig W; Lesnikoski BA; Pierson RN; Hancock WW; Candinas D; White DJ; Bach FH
    Transplantation; 1996 Mar; 61(6):862-8. PubMed ID: 8623150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs.
    Smolenski RT; Forni M; Maccherini M; Bacci ML; Slominska EM; Wang H; Fornasari P; Giovannoni R; Simeone F; Zannoni A; Frati G; Suzuki K; Yacoub MH; Lavitrano M
    Cardiovasc Res; 2007 Jan; 73(1):143-52. PubMed ID: 17134686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.